statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032 Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032 PR Newswire VANCOUVER...

Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032

Positive high-level results from an interim analysis of the ECHO Phase III trial showed AstraZenecas CALQUENCE (acalabrutinib) in combination with standard-of-care chemoimmunotherapy, bendamustine...

CALQUENCE combination regimen demonstrated statistically significant and clinically meaningful improvement in progression-free survival in 1st-line mantle cell lymphoma in ECHO Phase III trial

Study Finds Elevated Risk Of Eye Inflammatory Disorder Following COVID-19 Vaccination

 Authored by Megan Redshaw, J.D. via The Epoch Times (emphasis ours),

People with a history of...

Study Finds Elevated Risk Of Eye Inflammatory Disorder Following COVID-19 Vaccination

AstraZeneca will showcase new clinical and real-world data across its leading inhaled, biologic and early science respiratory portfolio at the American Thoracic Society (ATS) International...

AstraZeneca unveils latest research across key respiratory and immune-mediated diseases at ATS 2024 showcasing strength of its broad pipeline and portfolio

The agency sent letters to Novo Nordisk, AstraZeneca, Boehringer Ingelheim, Covis Pharma, GlaxoSmithKline, Novartis, Teva Pharmaceuticals, among others...

FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic

Discover the latest on AstraZeneca's Covid vaccine lawsuit. Allegations of serious side effects, including fatalities and brain injuries, spark legal battles. Learn about the controversy and...

AstraZeneca Admits Its COVID-19 Vaccine May Cause Blood Clotting Side Effect In Very Rare Case, But Causal Mechanism Unknown

Results from AstraZeneca's Enhertu trial vs. chemotherapy in HR-positive, HER2-low metastatic breast cancer.
read more...

Double Good News For AstraZeneca's Breast Cancer Drugs

Positive high-level results from the DESTINY-Breast06 Phase III trial showed that ENHERTU (fam-trastuzumab deruxtecan-nxki) demonstrated a statistically significant and clinically meaningful...

ENHERTU (fam-trastuzumab deruxtecan-nxki) improved PFS in HER2-low and ultralow

AstraZeneca CEO talks blowout earnings, global growth, new drugs, and pricing...

AstraZeneca CEO talks blowout earnings, global growth, new drugs, and pricing

AstraZeneca Shares Jump Most Since 2020...

AstraZeneca Shares Jump Most Since 2020

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Watchers	18,339
52-Wk Low	$60.47
52-Wk High	$76.80

Volume	54,421.00
52-Wk High	$76.80
52-Wk Low	$60.47

AZN AstraZeneca PLC

About

Feed

News

Sentiment

Fundamentals

Sentiment

Message Volume

Community